Reduced Levels of miR-145-3p Drive Cell Cycle Progression in Advanced High-Grade Serous Ovarian Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.MicroRNA-145-3p (miR-145-3p) is downregulated in high-grade serous ovarian cancer (HGSOC) due to DNA methylation. Restoring miR-145-3p may offer a new therapeutic strategy for HGSOC by inhibiting cell migration and proliferation.
Area Of Science
- Gynecologic Oncology
- Epigenetics
- Molecular Biology
Background
- High-grade serous ovarian cancer (HGSOC) is a lethal gynecologic malignancy with poor prognosis and limited therapeutic options.
- Epigenetic dysregulation, including microRNAs (miRNAs) and DNA methylation, is implicated in HGSOC progression but requires further elucidation.
- Understanding these epigenetic mechanisms is crucial for developing novel treatment strategies.
Purpose Of The Study
- To identify dysregulated miRNAs in HGSOC using high-throughput analysis.
- To investigate the epigenetic regulation, specifically DNA methylation, of identified miRNAs.
- To explore the functional role of a key miRNA, miR-145-3p, in HGSOC cell behavior.
Main Methods
- Comprehensive high-throughput screening to identify differentially expressed miRNAs in HGSOC tissues.
- Quantitative reverse transcription PCR (RT-qPCR) for miRNA validation in patient samples and cell lines.
- DNA methylation analysis to assess epigenetic control of miRNA expression.
- Functional assays (cell migration, cell cycle analysis) to determine the impact of miR-145-3p modulation.
Main Results
- Twenty differentially expressed miRNAs were identified in HGSOC, with 11 validated by RT-qPCR.
- miR-145-3p was consistently downregulated in advanced-stage HGSOC and post-neoadjuvant therapy, distinguishing tumor from control tissues.
- DNA methylation was confirmed as the regulatory mechanism controlling *MIR145* expression.
- Overexpression of miR-145-3p suppressed HGSOC cell migration and induced G0/G1 cell cycle arrest via the cyclin D1-CDK4/6 pathway.
Conclusions
- Downregulation of miR-145-3p, driven by DNA methylation, promotes cell proliferation and migration in HGSOC.
- Restoration of miR-145-3p represents a potential therapeutic strategy targeting G1/S phase regulation in HGSOC treatment.
- This study highlights the critical role of epigenetic modifications in HGSOC pathogenesis and identifies a promising biomarker and therapeutic target.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...